CDK12: A Potent Target and Biomarker for Human Cancer Therapy

Cells. 2020 Jun 18;9(6):1483. doi: 10.3390/cells9061483.

Abstract

Cyclin-dependent kinases (CDKs) are a group of serine/threonine protein kinases and play crucial roles in various cellular processes by regulating cell cycle and gene transcription. Cyclin-dependent kinase 12 (CDK12) is an important transcription-associated CDK. It shows versatile roles in regulating gene transcription, RNA splicing, translation, DNA damage response (DDR), cell cycle progression and cell proliferation. Recently, increasing evidence demonstrates the important role of CDK12 in various human cancers, illustrating it as both a biomarker of cancer and a potential target for cancer therapy. Here, we summarize the current knowledge of CDK12, and review the research advances of CDK12's biological functions, especially its role in human cancers and as a potential target and biomarker for cancer therapy.

Keywords: DNA damage response; cancer therapy; cell cycle; cell proliferation; cyclin-dependent kinase 12; gene transcription.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Biomarkers, Tumor / antagonists & inhibitors
  • Biomarkers, Tumor / genetics
  • Biomarkers, Tumor / physiology*
  • Cell Cycle / genetics
  • Cell Cycle / physiology
  • Cyclin-Dependent Kinases / antagonists & inhibitors
  • Cyclin-Dependent Kinases / genetics
  • Cyclin-Dependent Kinases / physiology*
  • DNA Damage
  • DNA Repair
  • Female
  • Gene Expression
  • Humans
  • Male
  • Neoplasms / enzymology*
  • Neoplasms / genetics
  • Neoplasms / therapy
  • Protein Biosynthesis
  • RNA Splicing
  • Transcription, Genetic

Substances

  • Biomarkers, Tumor
  • CDK12 protein, human
  • Cyclin-Dependent Kinases